HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bohlega, S. Articles by Cupler, E. J. Search for Related Content PubMed PubMed Citation Articles by Bohlega, S. Articles by Cupler, E. J. Related Collections All Neuromuscular Disease Muscle disease

Autosomal dominant hyaline body myopathy

Clinical variability and pathologic findings

From the Departments of Neurosciences (Drs. Bohlega, Al Said, and Cupler), Pathology and Laboratory Medicine (Drs. Lach and Al Homsi), and Genetics (Drs. Meyer and Kambouris), King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Address correspondence and reprint requests to Dr. S. Bohlega, Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, PO Box 3354 (MBC 76), Riyadh, 11211, Saudi Arabia; e-mail: boholega{at}kfshrc.edu.sa

Objective: To report clinical, morphologic, and immunohistochemical studies on autosomal dominant, clinically nonprogressive, and not previously described progressive forms of hyaline body (HB) myopathy (HBM) in a Saudi Arabian kindred.

Results: Muscle biopsies from four patients showed HB in type 1 fibers; they were positive for ATPase at pH 4.3/4.6 and for heavy chain slow myosin (HCSM); some HB were HCSM negative. HB were nonreactive for B-crystallin, ubiquitin, tropomyosin, actins, desmin, and components of sarcolemma. Ultrastructurally, HB were granular and filamentous or amorphous, often with fragments of sarcomeres, and surrounded by a zone of sarcomeric disorganization. All biopsies showed "myopathic" changes, angulated neurogenic fibers, and fiber type grouping. There was no correlation between HB and course of disease; the progressive cases displayed more severe myopathic features.

Conclusions: Formation of hyaline bodies in hyaline body myopathy is associated with either myolysis or defective incorporation of heavy chain slow myosin into the cytoskeleton. Hyaline bodies very likely contain additional unidentified proteins. Neurogenic factors are also involved in the hyaline body myopathy pathogenesis.

Received April 14, 2003. Accepted in final form July 26, 2003.

This article has been cited by other articles:

				T. Z. Armel and L. A. Leinwand Mutations in the {beta}-myosin rod cause myosin storage myopathy via multiple mechanisms PNAS, April 14, 2009; 106(15): 6291 - 6296. [Abstract] [Full Text] [PDF]

				G. Tomelleri, L. Palmucci, P. Tonin, T. Mongini, M. Marini, R. L'Erario, N. Rizzuto, and G. Vattemi SERCA1 and calsequestrin storage myopathy: a new surplus protein myopathy Brain, August 1, 2006; 129(8): 2085 - 2092. [Abstract] [Full Text] [PDF]

				N. G. Laing, C. Ceuterick-de Groote, D. E. Dye, K. Liyanage, R. M. Duff, B. Dubois, W. Robberecht, R. Sciot, J-J. Martin, and H. H. Goebel Myosin storage myopathy: Slow skeletal myosin (MYH7) mutation in two isolated cases Neurology, February 8, 2005; 64(3): 527 - 529. [Abstract] [Full Text] [PDF]

				S. Bohlega, S. N. Abu-Amero, S. M. Wakil, P. Carroll, R. Al-Amr, B. Lach, Y. Al-Sayed, E. J. Cupler, and B. F. Meyer Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy Neurology, May 11, 2004; 62(9): 1518 - 1521. [Abstract] [Full Text] [PDF]